TRAX

41.6406.34%
PF

Paul F. Lizzul

Chief Medical Officer

Dr. Paul F. Lizzul, M.D., Ph.D., M.P.H., M.B.A., FAAD is Chief Medical Officer of First Tracks Biotherapeutics, Inc. since April 20, 2026. Dr. Lizzul was Chief Medical Officer of AnaptysBio, Inc. since July 2020 until April 20, 2026. Dr. Lizzul previously served as Executive Medical Director of Amgen Inc, a pharmaceutical company, from January 2020 to July 2020. He was Chief Medical Officer at Sienna Biopharmaceuticals, Inc. since January 2016 to December 2019. Dr. Lizzul had been Senior Medical Director and Head of Safety at Kythera Biopharmaceuticals, Inc. since August 2012 until October 2015. Dr. Lizzul has a broad depth of knowledge and experience in both clinical and bench research and medical practice. He served as Senior Medical Director, Head of Safety at Sienna Biopharmaceuticals, Inc. and program lead for setipiprant (PGD2 inhibitor for AGA) at Kythera from August 2012 until it was acquired by Allergan in October 2015. Dr. Lizzul has authored articles in academic journals on topics including inflammation, psoriasis, aesthetics (Kybella) and health care reform. He is a diplomat of the American Board of Dermatology and a faculty member of the American Academy of Dermatology (AAD). He holds leadership positions within the national dermatology community and also held the distinction of serving on the Food and Drug Administration (FDA) Dermatology and Ophthalmic Drugs Advisory Committee. Prior to joining KYTHERA, Dr. Lizzul served as an Assistant Professor of Dermatology and Associate Director of Clinical Research at Tufts Medical Center. Dr. Lizzul is a volunteer member of the teaching faculty in the Department of Dermatology at University of California, Los Angeles School of Medicine. Dr. Lizzul completed post-graduate medical internship at Greenwich Hospital, Yale University School of Medicine and his dermatology residency at the University of California. He is a Summa Cum Laude graduate of Rensselaer Polytechnic Institute and received his M.D., Ph.D. degrees in Molecular Genetics and Microbiology and M.P.H. in Epidemiology/Outcomes from the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School. Dr. Lizzul holds M.B.A. in Entrepreneurship from the Rutgers Business School and is the recipient of numerous awards and accolades, including appointment to the American Academy of Dermatology (AAD) academic leadership program, the American Society of Dermatologic Surgery (ASDS) mentorship award, the Dr. Alan Scott Research Award from the American Society of Cosmetic Dermatology and Aesthetic Surgery (ASCDAS), a Gallo award for outstanding Cancer Research and recipient of NIH training grants.

Positions